Sökning: id:"swepub:oai:gup.ub.gu.se/281855" >
Current clinical pr...
Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies
-
Na, I. K. (författare)
-
Buckland, M. (författare)
-
Agostini, C. (författare)
-
visa fler...
-
Edgar, J. D. M. (författare)
-
- Friman, Vanda, 1952 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
-
Michallet, M. (författare)
-
Sanchez-Ramon, S. (författare)
-
Scheibenbogen, C. (författare)
-
Quinti, I. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2019-03-24
- 2019
- Engelska.
-
Ingår i: European Journal of Haematology. - : Wiley. - 0902-4441 .- 1600-0609. ; 102:6, s. 447-456
- Relaterad länk:
-
https://onlinelibrar...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective Despite long-standing safe and effective use of immunoglobulin replacement therapy (IgRT) in primary immunodeficiency, clinical data on IgRT in patients with secondary immunodeficiency (SID) due to B-cell lymphoproliferative diseases are limited. Here, we examine the correlation between approved IgRT indications, treatment recommendations, and clinical practice in SID. Methods An international online survey of 230 physicians responsible for the diagnosis of SID and the prescription of IgRT in patients with hematological malignancies was conducted. Results Serum immunoglobulin was measured in 83% of patients with multiple myeloma, 76% with chronic lymphocytic leukemia, and 69% with non-Hodgkin lymphoma. Most physicians (85%) prescribed IgRT after >= 2 severe infections. In Italy, Germany, Spain, and the United States, immunoglobulin use was above average in patients with hypogammaglobulinemia, while in the UK considerably fewer patients received IgRT. The use of subcutaneous immunoglobulin was highest in France (34%) and lowest in Spain (19%). Immunologists measured specific antibody responses, performed test immunization, implemented IgRT, and used subcutaneous immunoglobulin more frequently than physicians overall. Conclusions The management of SID in hematological malignancies varied regionally. Clinical practice did not reflect treatment guidelines, highlighting the need for robust clinical studies on IgRT in this population and harmonization between countries and disciplines.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- chronic lymphocytic leukemia
- hematological disorders
- immunoglobulins
- infection
- international
- chronic lymphocytic-leukemia
- immunoglobulin replacement therapy
- multiple-myeloma
- intravenous immunoglobulin
- antibody deficiency
- subcutaneous immunoglobulin
- immune-deficiency
- guidelines
- rituximab
- hypogammaglobulinemia
- Hematology
- apel h
- 1994
- british journal of haematology
- v88
- p209
- apel hm
- 1994
- lancet
- v343
- p1059
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Na, I. K.
-
Buckland, M.
-
Agostini, C.
-
Edgar, J. D. M.
-
Friman, Vanda, 1 ...
-
Michallet, M.
-
visa fler...
-
Sanchez-Ramon, S ...
-
Scheibenbogen, C ...
-
Quinti, I.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Göteborgs universitet